John McDaniel
Family Medicine · Zionsville, INNPI 1932294204
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,021 and has fallen 97.4% since, to $27 in 2024.
Across 119 payments — averaging $15.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$392
- AstraZeneca$323
- Johnson & Johnson$265
- Lilly USA, LLC$178
- Pfizer$147
- AbbVie$132
- plus $463 from 17 others
What the payments were for
- Food & beverage$1,892100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 28 | $392 |
| AstraZeneca | 17 | $323 |
| Johnson & Johnson | 15 | $265 |
| Lilly USA, LLC | 12 | $178 |
| Pfizer | 10 | $147 |
| AbbVie(2 entities) | 8 | $132 |
| Astellas Pharma US Inc | 4 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Eisai Inc. | 2 | $43 |
| Sanofi-aventis U.S. LLC | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $40 |
| Amgen(2 entities) | 2 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $24 |
| Amarin Pharma, Inc. | 1 | $20 |
| Duchesnay USA Incorporated | 1 | $19 |
| Tris Pharma Inc | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Merck | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| GSK | 1 | $11 |
How this compares
$1,898 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Zionsville
- Max LewisZionsville$15K
- Daniel ShullZionsville$15K
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.